Archives of Sexual Behavior

, Volume 26, Issue 3, pp 231–241 | Cite as

Effect of Testosterone Administration on Sexual Behavior and Mood in Men with Erectile Dysfunction

  • Raul C. Schiavi
  • Daniel White
  • John Mandeli
  • Alice C. Levine

Abstract

This double-blind placebo controlled, cross-over study was carried out to assess the effect of testosterone administration on sexual behavior mood, and psychological symptoms in healthy men with erectile dysfunction. Biweekly injections of 200 mg of testosterone enanthate were given over a period of 6 weeks separated by a washout period of 4 weeks. Blood samples for hormonal assessment, behavioral and psychological ratings were obtained prior to each injection. Luteinizing hormone remained significantly depressed but circulating testosterone had returned to baseline levels by 2 weeks following each hormonal injection. The ejaculatory frequency during the testosterone phase was statistically higher than during the placebo phase. There were marked, although statistically nonsignificant, increases in median frequency of reported sexual desire, masturbation, sexual experiences with partner, and sleep erections during the testosterone period. Testosterone did not have demonstrable effects on ratings of penile rigidity and sexual satisfaction. Mood variables and psychological symptoms did not change following hormonal administration. Results suggest that androgen administration to eugonadal men with erectile dysfunction may activate their sexual behavior without enhancing erectile capacity and without effects on mood and psychological symptoms.

testosterone androgens luteinizing hormone sexual behavior erectile dysfunction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. Anderson, R. A., Bancroft, J., and Wu, F. C. W. (1992). The effects of exogenous testosterone on sexuality and mood in normal men. J. Clin. Endocrinol. Metab. 75: 1503–1507.Google Scholar
  2. Bancroft, J., (1984). Androgens, sexuality and the ageing male. In Labrie, F., Proulx (eds.), Endocrinology, Elsevier, Amsterdam, pp. 913–917.Google Scholar
  3. Bancroft, J. (1988). Reproductive hormones and male sexual function In J. M. A. Sitson (ed.), Handbook of Sexology, Vol. 6, Elsevier, Amsterdam, pp. 297–315.Google Scholar
  4. Benkert, O., Witt, W., Adam, W., and Leitz, A. (1979). Effects of testosterone undecanoate on sexual potency and the hypothalamic-pituitary-gonadal axis of impotent males. Arch. Sex. Behav. 8: 471–479.Google Scholar
  5. Carani, C., Zini, D., Baldini, A., Della Casa, L., Ghizzani, A., and Marrama, P. (1990). Effects of androgen treatment in impotent men with normal and low levels of free testosterone. Arch. Sex. Behav. 19: 223–234.Google Scholar
  6. Davidson, J. M., Camargo, C., and Smith, E. R. (1979). Effects of androgen on sexual behavior in hypogonadal men. J. Clin. Endocrinol. Metal. 48: 955–958.Google Scholar
  7. Derogatis, L. R. (1977). SCL-90-R: Administration, Scoring and Procedures Manual, Clinical Psychometrics Research, Baltimore.Google Scholar
  8. Fogel, M., Rubin, B. L., and Ossowski, R. (1972). Serum FSH, LH and progesterone in single and multiple gestations following induction of ovulation. Am. J. Obstet. Gynecol. 112: 629–639.Google Scholar
  9. Furuyama, S., Mayes, D. M., and Nugent, C. A. A. (1970). A radioimmunoassay for plasma testosterone. Steroids 16: 115–428.Google Scholar
  10. Grizzle, J. F. (1965). The two period change-over design and its use in clinical trials. Biometrics 21: 467–480.Google Scholar
  11. Hwang, P., Guyda, H. J., and Friesen, H. G. (1971). A radioimmunoassay for human prolactin. Proc. Nat. Acad. Sci. 68: 1902–1906.Google Scholar
  12. Koch, G. G. (1972). The use of nonparametric methods in the statistical analysis of the two-period change-over design. Biometrics 28: 577–584.Google Scholar
  13. Kwan, M., Greenleaf, W. J., Mann, J., Crapo, L., and Davidson, J. M. (1983). The nature of androgenization on male sexuality: combined laboratory self-report study on hypogonadal men. J. Clin. Endocrinol. Metab. 57: 557–562.Google Scholar
  14. Mc Nair, D. M., Lorr, M., and Droppleman, L. F. (1971). Profile of Mood States Manual, Educational & Industrial Testing Service, San Diego, CA.Google Scholar
  15. O'Carroll, R., and Bancroft, J. (1984). Testosterone therapy for low sexual interest and erectile dysfunction in men: A controlled study. Br. J. Psychiat. 145: 146–151.Google Scholar
  16. O'Carroll, R., Shapiro, C., and Bancroft, J. (1985). Androgens, behavior and nocturnal erection in hypogonadal men: the effects of varying the replacement dose. Clin. Endocrinol. 23: 527–538.Google Scholar
  17. Pirke, K. M., and Kockott, G. (1982). Endocrinology of sexual function. Clin. Endocrinol. Metab. 11: 625–634.Google Scholar
  18. Puri, V., Puri, C. P., and Kumar, T. C. A. (1981). Serum levels of dihydrotestosterone in male rhesus monkeys estimated by a nonchromatographic radioimmunoassay method. J. Steroid Biochem. 14: 877–881.Google Scholar
  19. Reynolds, C. F., III, Frank, F., Thase, M. F., Houck, P. R., Jennings, J. R., Howell, J. R., Lilienfeld, S. O., and Kupfer, D. J. (1988). Assessment of sexual function in depressed, impotent and healthy men: Factor analysis of a brief sexual function questionnaire for men. Psychiat. Res. 24: 231–250.Google Scholar
  20. Salmimies, P., Kockott, G., Pirke, K. M., Vogt, H. J., and Schill, W. B. (1982). Effects of testosterone replacement on sexual behavior in hypogonadal men. Arch. Sex. Behav. 11: 345–353.Google Scholar
  21. Schiavi, R. C., White, D., Mandeli, J., and Schreiner-Engel, P. (1993). Hormones and nocturnal penile tumescence in healthy aging men. Arch. Sex. Behav. 22: 207–215.Google Scholar
  22. Selzer M. (1971). The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument. Am. J. Psychiat. 127: 1653–1658.Google Scholar
  23. Skakkebaek, N. E., Bancroft, J., Davidson, D. W., and Warner, P. (1981). Androgen replacement with oral testosterone undercanoate in hypogonadal men: a double blind controlled study. Clin. Endocrinol. 14: 49–61.Google Scholar
  24. Snyder, P., and Lawrence, D. A. (1980). Treatment of male hypogonadism with testosterone enanthate. J. Clin. Endocrinol. Metab. 51: 1335–1339.Google Scholar
  25. Sokol, R. Z. Palacios, A., Campfield, L. A., Saul, C., and Swerdloff, R. S. (1982). Comparison of the kinetics of injectable testosterone in eugonadal and hypogonadal men. Fertil. Steril. 37: 425–430.Google Scholar
  26. Spanier, G. B. (1976). Measuring dyadic adjustment: New scale for assessing the quality of marriage and similar dyads. J. Marr. Fam. 38: 15–29.Google Scholar
  27. Tremblay, R. R., and Dube, J. Y. (1974). Plasma concentrations of free and nonTeBG bound testosterone in women on oral contraceptives. Contraception 10: 599–605.Google Scholar
  28. Wu, F. C. W., Bancroft, J., Davidson, D. W., and Nicol, K. (1982). The behavioral effects of testosterone undecanoate in adult men with Klinefelter's syndrome: A controlled study. Clin. Endocrinol. 16: 489–497.Google Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  • Raul C. Schiavi
    • 1
  • Daniel White
    • 2
  • John Mandeli
    • 2
  • Alice C. Levine
    • 2
  1. 1.Human Sexuality Program, Department of PsychiatryMount Sinai School of MedicineNew York
  2. 2.The Mount Sinai School of MedicineNew York

Personalised recommendations